Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[A case of hyperlipemia]

S Condorelli, F Patanè, D Lombardi

    Bollettino Della Societa Italiana Di Cardiologia
    |January 1, 1975
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Performance of Ankle Exoskeletons on Irregular Terrains: Key Design Principles and Benchmarking Tests.

    IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society·2025
    Same author

    Impact of ultraviolet light disinfection on reducing hospital-associated infections: a systematic review in healthcare environments.

    The Journal of hospital infection·2025
    Same author

    MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy.

    Annals of oncology : official journal of the European Society for Medical Oncology·2024
    Same author

    The impact of COVID-19 pandemic control on vaccine-preventable invasive bacterial diseases in Piedmont (Italy).

    Infection·2022
    Same author

    A multicenter validation of the revised version of the Milan system for reporting salivary gland cytology (MSRSGC).

    Oral oncology·2020
    Same author

    Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial.

    Gynecologic oncology·2019